Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 14/20 | 0.53 |
| ▸ | F13A1 | P00488 | 11/20 | 0.53 |
| ▸ | TGM1 | P22735 | 8/20 | 0.51 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.48 |
| ▸ | STS | P08842 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26065734 | 0.93 | TGM2 (0.53) | TGM2F13A1TGM1TGM3STS | |
| SCHEMBL26065393 | 0.93 | TGM2 (0.53) | TGM2F13A1TGM1TGM3STS | |
| SCHEMBL25371790 | 0.87 | TGM2 (0.39) | TGM2F13A1TGM1GPR119EPHX2 | |
| SCHEMBL26065927 | 0.84 | TGM2 (0.52) | TGM2F13A1TGM1TGM3LMNA | |
| SCHEMBL26065348 | 0.83 | TGM2 (0.49) | TGM2F13A1TGM1TGM3LMNA | |
| SCHEMBL26065549 | 0.82 | TGM2 (0.53) | TGM2F13A1TGM1TGM3STS | |
| SCHEMBL26065416 | 0.81 | TGM2 (0.48) | TGM2F13A1TGM1TGM3LMNA | |
| SCHEMBL30719549 | 0.81 | NAMPT (0.44) | TGM2F13A1TGM1STSGPR119 | |
| SCHEMBL27346553 | 0.81 | NAMPT (0.44) | TGM2F13A1TGM1STSGPR119 | |
| SCHEMBL26065932 | 0.81 | TGM2 (0.57) | TGM2F13A1TGM1TGM3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164063-A1 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | BIOGEN MA INC. (US) | 2023-08-31 | — | — | WO | disclosed |